Episode 155: Brighter Days Ahead
The Osterholm Update: COVID-19
by CIDRAP
5d ago
<p>In "Brighter Days Ahead," Dr. Osterholm and Chris Dall discuss the latest national and international COVID trends, recent research on long COVID, and measles cases in the U.S. Dr. Osterholm also shares the latest "This Week in Public Health History" segment and interviews two members of the podcast team.</p> <p>Please fill out our <a href="https://redcap.ahc.umn.edu/redcap/surveys/?s=DKAXDYKTDXCN4HLT">Listener Feedback Survey</a>!</p> <p><a href="https://www.cidrap.umn.edu/covid-19/three-studies-spotlight-long-term-burden-covid-us-adults">Thre ..read more
Visit website
Episode 154: H5N1 Uncertainty
The Osterholm Update: COVID-19
by CIDRAP
2w ago
In "H5N1 Uncertainty," Dr. Osterholm and Chris Dall discuss the latest national COVID trends, a recent study on Paxlovid, and H5N1 avian flu virus infection in cattle. Dr. Osterholm also shares the latest "This Week in Public Health History" segment and interviews two members of the podcast team. Please fill out our Listener Feedback Survey! Swedish study suggests link between long COVID and severity of illness (Stephanie Soucheray, CIDRAP News) Study: long COVID affects 8% of those with COVID-19, is more common in women (Stephanie Soucheray, CIDRAP News) New neurologic issues l ..read more
Visit website
Episode 153: Good News in a COVID-Indifferent World
The Osterholm Update: COVID-19
by CIDRAP
1M ago
In "Good News in a COVID-Indifferent World," Dr. Osterholm and Chris Dall discuss the national and international COVID trends, the latest research on long COVID, and antibiotic resistant Shigella. Dr. Osterholm also shares the latest "This Week in Public Health History" segment and interviews members of the podcast team.  Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19 (Hanson et al., Nature Immunology) How Americans view the coronavirus, COVID-19 vaccines amid declining levels of concern (Tyson & Pasquini, Pew Researc ..read more
Visit website
Episode 152: A Tough Conversation
The Osterholm Update: COVID-19
by CIDRAP
1M ago
In "A Tough Conversation," Dr. Osterholm and Chris Dall discuss the new CDC COVID isolation guidelines, a measles outbreak in Florida, and the latest news on avian influenza. Dr. Osterholm also provides an update on influenza and RSV cases in the U.S. and shares the latest "This Week in Public Health History" segment. Background for CDC’s Updated Respiratory Virus Guidance (CDC) Support this podcast ..read more
Visit website
Episode 151: Harm Reduction
The Osterholm Update: COVID-19
by CIDRAP
2M ago
In this episode, Dr. Osterholm and Chris Dall discuss COVID isolation guidelines, the BA.2.87.1 variant, and the importance of measles and other rare public health threats.  ..read more
Visit website
Episode 149: A Period of Transition
The Osterholm Update: COVID-19
by CIDRAP
2M ago
In "A Period of Transition," Dr. Osterholm and Chris Dall discuss the latest COVID-19 trends in the U.S. and around the world, a recent study on long COVID, and the rise of measles cases in the United States. Dr. Osterholm also provides an update on influenza and RSV cases in the U.S. and shares the latest "This Week in Public Health History" segment.  Persistent complement dysregulation with signs of thromboinflammation in active long COVID (Cervia-Hasler et al., Science) Lighting up long COVID (Eric Topol, Ground Truths) Follow up, funding critical on long COVID (Jill Burcum ..read more
Visit website
Episode 149: A Period of Transition
The Osterholm Update: COVID-19
by CIDRAP
3M ago
In "A Period of Transition," Dr. Osterholm and Chris Dall discuss the latest COVID-19 trends in the U.S. and around the world, a recent study on long COVID, and the rise of measles cases in the United States. Dr. Osterholm also provides an update on influenza and RSV cases in the U.S. and shares the latest "This Week in Public Health History" segment.  Persistent complement dysregulation with signs of thromboinflammation in active long COVID (Cervia-Hasler et al., Science) Lighting up long COVID (Eric Topol, Ground Truths) Follow up, funding critical on long COVID (Jill Burcum ..read more
Visit website
Episode 148: No Time to Quit
The Osterholm Update: COVID-19
by CIDRAP
3M ago
In "No Time to Quit," Dr. Osterholm and Chris Dall discuss the JN.1 variant, Paxlovid uptake, and COVID-19 vaccine disinformation. Dr. Osterholm also provides an update on influenza and RSV transmission and shares the latest "This Week in Public Health History" segment.  Opinion: The U.S. is facing the biggest COVID wave since Omicron. Why are we still playing make-believe? (Eric Topol, LA Times) Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It (Christina Jewett, New York Times) COMMENTARY: What can masks do? Part 1: The science behind COVID-19 protection (Bro ..read more
Visit website
Episode 147: JN.1, Hospital Capacity, & Vaccine Uptake
The Osterholm Update: COVID-19
by CIDRAP
4M ago
In this episode, Dr. Osterholm and Chris Dall discuss the JN.1 variant, the rising levels of SARS-CoV-2 in wastewater, and the low uptake of the COVID-19, RSV, and influenza vaccines. Dr. Osterholm also shares his thoughts on hospital capacity issues in the U.S. and shares the latest "This Week in Public Health History" segment.  Support this podcast ..read more
Visit website
Episode 146: A Seasonless Virus
The Osterholm Update: COVID-19
by CIDRAP
4M ago
In "A Seasonless Virus," Dr. Osterholm and Chris Dall discuss the latest COVID-19 trends in the U.S. and around the world, provide an update on influenza and RSV activity, and review two recent studies on long COVID. Dr. Osterholm also answers a listener question on fomite transmission of SARS-CoV-2 and celebrates a recent event in public health history.  Report underscores financial pressure of long COVID on families (CIDRAP News) 5% of COVID-infected US veterans still had symptoms up to 1 year later (CIDRAP News) SARS-CoV-2 disease severity and transmission efficiency is increase ..read more
Visit website

Follow The Osterholm Update: COVID-19 on FeedSpot

Continue with Google
Continue with Apple
OR